Ignite Creation Date:
2025-12-24 @ 11:08 PM
Ignite Modification Date:
2026-03-01 @ 3:21 AM
Study NCT ID:
NCT02782169
Status:
COMPLETED
Last Update Posted:
2018-04-19
First Post:
2015-11-30
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Prophylactic Pregabalin to Decrease Pain During Medical Abortion
Sponsor:
University of Hawaii
Organization:
Study Overview
Official Title:
Prophylactic Pregabalin to Decrease Pain During Medical Abortion: a Randomized Controlled Trial
Status:
COMPLETED
Status Verified Date:
2018-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Medical abortion has been associated with significant pain. The objective of this trial is to determine whether one dose of pregabalin 300 mg, given during medical abortion in addition to the standard of care analgesics, will decrease experienced pain. Investigators will perform a randomized, double-blinded, placebo-controlled trial. Participant pain levels and side effects will be assessed at multiple time points, along with a measure of satisfaction.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
True
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: